Vanessa Rousseau

Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial

David Malka, Pascale Cervera, Stéphanie Foulon et al. · The Lancet Oncology · 2014 · 414 citations · Full text

Medicine, Oncology, Pharmacology +14

ERCC1 Isoform Expression and DNA Repair in Non–Small-Cell Lung Cancer

Luc Friboulet, Ken A. Olaussen, Jean‐Pierre Pignon et al. · New England Journal of Medicine · 2013 · 363 citations · Full text

Medicine, Molecular Biology, Oncology +12

The Use of Rifaximin in the Prevention of Overt Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt

Christophe Bureau, Dominique Thabut, Caroline Jézequel et al. · Annals of Internal Medicine · 2021 · 183 citations

Pharmacy, Pharmacology, Pharmacotherapy +16

IGF2BP1 enhances an aggressive tumor cell phenotype by impairing miRNA-directed downregulation of oncogenic factors

Simon Müller, Nadine Bley, Markus Glaß et al. · Nucleic Acids Research · 2018 · 140 citations · Full text

Medicine, Cancer Biology, Oncology +16

MutS Homologue 2 and the Long-term Benefit of Adjuvant Chemotherapy in Lung Cancer

Nermine S. Kamal, Jean‐Charles Soria, Jean Mendiboure et al. · Clinical Cancer Research · 2010 · 110 citations · Full text

Medicine, Oncology, Chemotherapy +12